How is Zepbound different from other GLP-1 medications
For participants who received GLP-1RAs therapy for more than six months, the intercept estimates were positive for age and gender and negative for baseline weight, indicating a potential increase in WL
However, anecdotal reports from some patients suggest changes in sexual function during treatment, which may be attributed to several indirect mechanisms rather than a direct pharmacological effect of the medication itself
Martin CMA, Irwin N, Flatt PR, Gault VA (2013) A novel acylated form of (d-Ala(2))GIP with improved antidiabetic potential, lacking effect on body fat stores
Further clinical evaluation (e.g., rheumatology referral) may be appropriate for patients who develop signs or symptoms of peripheral vasculopathy